Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate (Q43784087)
scientific article published on August 1, 2001
Language:
Current Data About Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
(P31) (Q13442814)
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

(P304) 8-15
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

(P407) (Q1860)
(P248)
(P698) 11685723
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11685723
(P813) Friday, January 24, 2025

(P433) 4 Suppl 15
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

(P478) 28
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

(P577) Wednesday, August 1, 2001
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

Wednesday, August 1, 2001
(P248)
(P698) 11685723
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11685723
(P813) Friday, January 24, 2025

(P921) (Q42824440)

(Q6823250)
(P887)

(Q420436)
(P887)

(Q7689669)
(P248)
(P698) 11685723
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11685723
(P813) Friday, January 24, 2025

(P953) https://api.elsevier.com/content/article/PII:S0093775401901496?httpAccept=text/xml
(P248)
(P356) 10.1016/S0093-7754(01)90149-6
(P854) https://api.crossref.org/works/10.1016/S0093-7754(01)90149-6
(P813) Friday, January 24, 2025

https://api.elsevier.com/content/article/PII:S0093775401901496?httpAccept=text/plain
(P248)
(P356) 10.1016/S0093-7754(01)90149-6
(P854) https://api.crossref.org/works/10.1016/S0093-7754(01)90149-6
(P813) Friday, January 24, 2025

(P1433) (Q14330412)
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

(P1476) "Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate" (language: en)
(P248)
(P698) 11685723
(P813) Sunday, November 26, 2017

(P2093) W. Berry
(P1545) 1
(P248)
(P698) 11685723
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11685723
(P813) Friday, January 24, 2025

S. Dakhil
(P1545) 2
(P248)
(P698) 11685723
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11685723
(P813) Friday, January 24, 2025

M. A. Gregurich
(P1545) 3
(P248)
(P698) 11685723
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11685723
(P813) Friday, January 24, 2025

L. Asmar
(P1545) 4
(P248)
(P698) 11685723
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11685723
(P813) Friday, January 24, 2025

other details
description scientific article published on August 1, 2001

External Links
(P356) 10.1016/S0093-7754(01)90149-6
(P698) 11685723